Curcumin formulations for better bioavailability: what we learned from clinical trials thus far?

M Hegde, S Girisa, B BharathwajChetty, R Vishwa… - ACS …, 2023 - ACS Publications
Curcumin has been credited with a wide spectrum of pharmacological properties for the
prevention and treatment of several chronic diseases such as arthritis, autoimmune …

Effectiveness of curcumin on outcomes of hospitalized COVID-19 patients: A systematic review of clinical trials

A Vahedian-Azimi, M Abbasifard, F Rahimi-Bashar… - Nutrients, 2022 - mdpi.com
Despite the ongoing vaccination efforts, there is still an urgent need for safe and effective
treatments to help curb the debilitating effects of COVID-19 disease. This systematic review …

Role of turmeric and curcumin in prevention and treatment of chronic diseases: Lessons learned from clinical trials

AB Kunnumakkara, M Hegde, D Parama… - ACS Pharmacology & …, 2023 - ACS Publications
Turmeric (Curcuma longa) has been used for thousands of years for the prevention and
treatment of various chronic diseases. Curcumin is just one of> 200 ingredients in turmeric …

Effect of nano‐curcumin on various diseases: a comprehensive review of clinical trials

S Hassanizadeh, M Shojaei, M Bagherniya… - Biofactors, 2023 - Wiley Online Library
The antioxidant, anti‐inflammatory, and antibacterial properties of curcumin have made it a
valuable herbal product for improving various disorders, such as COVID‐19, cancer …

Oral co-supplementation of curcumin, quercetin, and vitamin D3 as an adjuvant therapy for mild to moderate symptoms of COVID-19—Results from a pilot open-label …

A Khan, S Iqtadar, SU Mumtaz, M Heinrich… - Frontiers in …, 2022 - frontiersin.org
Background: Curcumin, quercetin, and vitamin D3 (cholecalciferol) are common natural
ingredients of human nutrition and reportedly exhibit promising anti-inflammatory …

The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized …

G Askari, A Sahebkar, D Soleimani, A Mahdavi… - Trials, 2022 - Springer
Background COVID-19 pandemic has made the disease a major global problem by creating
a significant burden on health, economic, and social status. To date, there are no effective …

Curcumin extraction, isolation, quantification and its application in functional foods: a review with a focus on immune enhancement activities and COVID-19

S Tripathy, DK Verma, M Thakur, AR Patel… - Frontiers in …, 2021 - frontiersin.org
An entirely unknown species of coronavirus (COVID-19) outbreak occurred in December
2019. COVID-19 has already affected more than 180 million people causing~ 3.91 million …

The effectiveness of nano‐curcumin on patients with COVID‐19: A systematic review of clinical trials

M Shojaei, S Foshati, M Abdi, G Askari… - Phytotherapy …, 2023 - Wiley Online Library
The main aim of the current study was to summarize the findings of available clinical studies
to assess nano‐curcumin's influence on COVID patients. A comprehensive online search …

Curcumin-based nanomedicines in the treatment of inflammatory and immunomodulated diseases: An evidence-based comprehensive review

LF Laurindo, GM de Carvalho, B de Oliveira Zanuso… - Pharmaceutics, 2023 - mdpi.com
Curcumin (CUR) is a polyphenol extracted from the rhizome of Curcuma longa that
possesses potent anti-inflammatory and antioxidant potential. Despite CUR's numerous …

Bioactive compounds from the Zingiberaceae Family with known antioxidant activities for possible therapeutic uses

RN Alolga, F Wang, X Zhang, J Li, LSP Tran, X Yin - Antioxidants, 2022 - mdpi.com
The Zingiberaceae family is a rich source of diverse bioactive phytochemicals. It comprises
about 52 genera and 1300 species of aromatic flowering perennial herbs with characteristic …